The 2026 LiBBY findings do not change routine care yet for adult children because safety questions remain unresolved. LiBBY, short for Life's End Benefits of cannaBidiol and tetrahYdrocannabinol, was a 12-week Phase 2 trial, not proof of a safe home treatment.
The study tested 2 mg THC with 100 mg CBD twice daily in 120 hospice-eligible patients with dementia-related agitation. Agitation means restlessness, aggression, or distress that makes daily care unsafe. Families saw a strong improvement signal, but more serious harms also appeared on active treatment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who was in the LiBBY trial?
- How strong was the agitation benefit?
- Why do the safety numbers matter more here?
- Why is dispensary cannabis not the same thing?
- What should adult children do about agitation now?
Who was in the LiBBY trial?
NeurologyLive reports the trial enrolled advanced dementia patients across 10 U.S. sites, with a mean age of 80 and 55% female.
Home and residence visits were used to include an end-of-life population often excluded from dementia trials. The Alzheimer's Association describes LiBBY as a multicenter, randomized, double-blind, placebo-controlled Phase 2 trial. Active treatment was a supervised oral THC and CBD combination given twice daily for 12 weeks.
How strong was the agitation benefit?
NeurologyLive reports active treatment met its primary agitation goal, with CMAI reduction at 2 weeks sustained through 12 weeks, a contrast of -8.23, in its LiBBY trial results. CMAI is a standard scale that rates restless, aggressive, and distressed behaviors.
Global improvement was also common. NeurologyLive reports improvement in 83.9% at week 2 and 87.2% at week 12 on THC and CBD, compared with 30.5% and 23.6% on placebo. The gap appeared early and persisted for the full 12 weeks.
Why do the safety numbers matter more here?
NeurologyLive reports similar overall adverse-event rates but more serious events on active drug, with serious adverse events in 23.3% versus 11.9% on placebo. Serious infections occurred in 11.7% versus 1.7%, and deaths occurred in 13.1% versus 5.1%.
Older adults face added cannabis-related risks. AARP points to higher risk of falls, memory problems, poor coordination, and changes in heart rate and blood pressure: That risk profile carries extra weight in frail, hospice-eligible patients. A treatment can reduce agitation scores while still creating infections, hospital transfers, or loss of comfort and function.
- fall or injury after standing, walking, or nighttime toileting
- confusion, daytime sleepiness, or worse memory
- unsteadiness, slowed reactions, or poor coordination
- racing pulse, dizziness, or blood-pressure shifts
Why is dispensary cannabis not the same thing?
NeurologyLive reports the findings apply only to a purified, supervised oral THC and CBD formulation and dosing system. They do not extend to varied dispensary or over-the-counter cannabis products with different strength, purity, and dosing.
The results were Phase 2 topline findings presented at AAIC 2026 in London, not an FDA approval, according to the Alzheimer's Association in its AAIC trial summary. Cleveland Clinic notes FDA has not approved marijuana for medical purposes and providers cannot prescribe it as such.
What should adult children do about agitation now?
Pennington Biomedical Research Center advises no change to routine care yet, with no home cannabis started for a parent, in its LiBBY guidance for families. Discuss agitation only through the dementia or hospice team so benefits, infections, sedation, falls, and drug interactions get weighed together.
Bring a short record to that visit: Ask the team what may be causing distress today and what supervised options fit your parent. Bring the agitation log to the next dementia or hospice visit and ask for a same-week review if episodes turn aggressive, frequent, or unsafe.
- when agitation happens, how long it lasts, and what happened before it
- sleep, pain, constipation, new drugs, missed doses, and recent illness
- falls, dizziness, sleepiness, appetite change, or fever
- full cannabis, CBD, sleep-aid, anxiety, and pain-product list
You Might Also Like
- LiBBY Trial Findings for Late-Stage Dementia Agitation in 2026: Why the Findings May Not Change Care Yet for Adult Children
- p-tau217 Findings a Decade Before Alzheimer’s Symptoms in 2026: Why the Findings May Not Change Care Yet for Adult Children
- Implementation-Ready Dementia Interventions in the 2026 NIA Report: What Researchers Still Need to Learn for Adult Children
